
Panel 40 Injection
Marketer
Vatican Life Sciences Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Panel 40 Injection
Intravenous administration of AcidControl 40 is indicated for reducing gastric acid secretion. This medication treats various acid-related gastrointestinal disorders, including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, offering symptomatic relief and facilitating healing. AcidControl 40 also prevents stress ulcers in critically ill patients and is prophylactically administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injection is exclusively administered intravenously by a healthcare provider when deemed more appropriate than oral administration. Dosage is individualized based on patient response and underlying condition, with treatment duration determined by the physician. Continued use as prescribed is crucial, even with rapid symptom resolution. Adjunctive lifestyle modifications, including frequent smaller meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment efficacy. Commonly reported mild side effects include nausea, vomiting, headache, vertigo, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical consultation. Prolonged therapy, particularly exceeding one year, may elevate the risk of bone fractures, especially at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your physician. AcidControl 40 is contraindicated in patients with severe hepatic impairment, those using HIV medications, those with a history of PPI allergy, or those with pre-existing osteoporosis. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or somnolence occurs.
Primary Ingredients of Panel 40 Injection
No text provided to rephrase.
Uses of Panel 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panel 40 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Panel 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Panel 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Panel 40 Injection works:
Injection Panel 40, a proton pump inhibitor, diminishes stomach acid production, thereby alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Panel 40 Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Panel 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Panel 40 Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Panel 40 Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Panel 40 Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
For individuals with significant hepatic impairment, Panel 40 Injection requires careful administration. Dosage modification of Panel 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Panel 40 Injection :
Omit a Panel 40 Injection dose? Seek medical advice immediately.
Facts to Know About Panel 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
